Mid-trimester termination for fetal abnormality: advantages of a new regimen using mifepristone and misoprostol.
Hinshaw
K
K
University Department of Obstetrics and Gynaecology, Aberdeen Maternity Hospital, UK.
el-Refaey
H
H
Rispin
R
R
Templeton
A
A
D000028:Abortion, Induced / Q000379:methods*; D000282:Administration, Intravaginal; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D005260:Female; D005333:Fetus / Q000002:abnormalities*; D006801:Humans; D015735:Mifepristone; D016595:Misoprostol; D011247:Pregnancy; D011262:Pregnancy Trimester, Second
D016595:Misoprostol; D015735:Mifepristone